Cuvitru 200 mg/ml
Cuvitru 200 mg/ml is a medicine authorised by Swissmedic under authorisation number 65992. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 October 2016 and the authorisation is valid without a time limit. ATC code J06BA01 places the medicine in the group Immune sera and immunoglobulins.
| Authorisation number | 65992 |
|---|---|
| Name | Cuvitru 200 mg/ml |
| Full name | Cuvitru 200 mg/ml, Injektionslösung |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | J06BA01 |
| First authorisation | 14 October 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cuvitru 200 mg/ml, Injektionslösung | B | 14 October 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | ml | J06BA01 | 08.09. | B |
| 2 | 10 | ml | J06BA01 | 08.09. | B |
| 3 | 20 | ml | J06BA01 | 08.09. | B |
| 4 | 40 | ml | J06BA01 | 08.09. | B |
| 5 | 50 | ml | J06BA01 | 08.09. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Cuvitru 200 mg/ml authorised in Switzerland?
Yes. Cuvitru 200 mg/ml is authorised by Swissmedic under authorisation number 65992, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cuvitru 200 mg/ml have?
Cuvitru 200 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cuvitru 200 mg/ml?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.